HOXB7 and neoplasm: Tumor weights were significantly lower in the HOXB7 shRNA group than in the control group (0.775±0.330 g vs. 4.475±0.126 g, P<0.001, Figure 3D) and the formation of lung metastatic lesions was markedly decreased in the HOXB7 shRNA group (2.750±0.957 vs. 21.500±4.123, P<0.001, Figure 3D).